Who We Are Our Products Our Services Our Capabilities Careers News & Insights Contact search LinkedIn Youtube Home Our Products Inhalation Inhalation devices A breath of expertise From the concept idea to large scale manufacturing, we’re the utmost holistic partner to develop your inhalers. We help our customers succeed in the sprint to market with their formulations targeting the inhalation treatments. We also are an active contributor to the scientific community and we strive to consider in our research evolving trends in inhalation and in patient needs, as well as increasing interest to digital and sustainability related factors. All Commercially available In development/Research Tailor-made for customers DPI and pMDI At Nemera, we are your holistic partner to develop and manufacture patient-centric inhalers Discover More CUPIDO We have been part of the EU-funded project CUPIDO, to find an innovative solution to deliver inhaled nanoparticles to the heart. Discover More Our services Integrated services from device selection to GMP manufacturing We have developed end-to-end services and expertise in inhaler development, device consulting, clinical trial support and contract manufacturing to complement our diverse portfolio of products to help you through every step of the journey. Discover more Early-stage Innovation and research We are an active contributor to the scientific community and we strive to consider in our researchs evolving trends in inhalation and in patient needs, as well as increasing interest in digital and sustainability-related factors. Discover more Testing capabilities Thanks to our high-end laboratory facilities we can test inhaler performances, as well as test methods development for our customers’ needs. Discover more FAQ What conditions are Nemera’s inhalation devices used for? Nemera designs and develops 2 types of inhalers, Pressurized Metered Dose Inhalers and Dry Powder Inhalers, to treat the following diseases: Asthma is a chronic inflammatory disease is a chronic disease of the air passages of the lungs which causes recurring symptoms, such as reversible airflow obstruction, episodes of wheezing, coughing, chest tightness, and shortness of breath. It was estimated that more than 339 million people had Asthma globally in 2016. There is no cure for asthma, but symptoms can be prevented by using of inhaled corticosteroids. COPD (Chronic obstructive pulmonary disease) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. Globally, it is estimated that 3.17 million deaths were caused by the disease in 2015 (that is, 5% of all deaths globally in that year). COPD treatments include smoking cessation, vaccinations, respiratory rehabilitation, and often inhaled bronchodilators and steroids. What is an inhaler? What is a DPI? What is a PMDI? Our product catalogue Inhalation Download Inhalation in the press "Patient Journey as a key to develop Inhalation combination products" Discover the article Related contents Knowledge Hub Cutting-edge insights, resources, press articles, and webinars to learn more about the holistic ecosystem of drug delivery device solutions. Discover more Who we are We design and manufacture devices that maximize treatment efficacy and partner with our customers in their device strategies, to ultimately bring high-quality and safe treatment solutions to patients. Discover more Get in touch Get in touch to find out more about us, our solutions and what we can do for you. If you’re looking for job opportunities, please visit: Join Our Team First Name*: Last Name*: Company Name*: Job Title*: State: Country*: Please select... Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegowina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d'Ivoire Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France France Metropolitan French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard and Mc Donald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao, People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands Spain Sri Lanka St. Helena St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Islands Western Sahara Yemen Yugoslavia Zambia Zimbabwe Email*: Phone: Main Interest*: Please select... Our Services Our Products Other Channel (how did you hear about us?)*: Please select... Search Engine Social Media Website Exhibitions Press Word of Mouth Third party network Other Message*: Your personal data is intended for Nemera and its subsidiaries to process your request for information. You have rights over your personal data, such as the right to access, erase and object. For more information, see our Privacy Policy. * Required fields. LinkedIn Twitter Youtube Who We Are Privacy Policy Cookies policy Legal Policy 20 Avenue de la Gare 38290 La Verpillière - France T. +33 4 74 94 06 54 © 2021 Nemera. Website developed by Illustrate Digital